, increasing from the same period of the previous year by Baht 53.75 million mainly due to increased construction revenue together with improved gross profit margin and increased share of profit from associated

gross profit increased by 121.43 and 121.70% y-o-y respectively. Other Revenue for Q2 2017 which are mostly gain from investment slightly increased. The slightly improved stock market led to higher

increased loan level and the completion of the BOI tax incentive scheme respectively. Net profit attributable to equity holders decreased Baht 181 million year-on-year, as improved earnings from core

in Malaysia. Cost of sales and services increased by only 1.2 percent while sales have increased by over 3 percent. As a result, gross profit margin as percentage of sales continuously improved, from

Component by Brand 3 2. Cost of goods sold and gross profit Gross profits for Y2019 and Y2018 represented 43.44%, and 40.90%, respectively, which increased previous year. Gross profits improved from higher

that will support continuous growth momentum in demand for medical devices in Thailand. In 2019, the Company has improved and increased the sales team to increase sales efficiency in distributor of

revenue increased by 20.3% year-on-year and reached Baht 8,197.2 million which is the highest revenue per quarter since the company has started the operation. Sales and service income increased by 20.7

in which all of them improved as well as agricultural incomes improved. The domestic car sales for the current quarter also increased compared to the previous year. As a result, total sales of company

performance improved significantly. Total revenue increased 35.2% from that in 2021 to Baht 28,348 million while our core net profit increased 119.4% from 2021 to Baht 1,761 million respectively. This was

and efforts to up-sell and deliver additional bundled products to uplift the ARPU. Enterprise and other service revenue increased by 6.7% YoY following the demand that returned after improved political